300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Sudan
Guernsey
Cameroon
Andorra
Colombia
Armenia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Qatar
Albania
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Spain
Mongolia
Angola
Europe
Cyprus
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Lucion, VC Fund

Lucion

VC Fund

Jinan, China

Lucion is an influential professional venture capital institute.

Total investments:
60
Last investment:
Lead investor:
45%

Last updated:

Industries Lucion invests in

BiotechnologyManufacturingMedicalHealth CareSoftware

Stages Lucion invests in

Series ASeries BFunding RoundSeedSeries C

Countries Lucion invests in

China

Round sizes

Series A $1.4M–$539MSeries B $2.8M–$144M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$1.4M–$539M
Series B
$2.8M–$144M

Investment Focus

Industry

  • Biotechnology 11 (18%)
  • Manufacturing 11 (18%)
  • Medical 9 (15%)
  • Health Care 8 (13%)
  • Software 5 (8%)
See all 55 industries →

Stage

  • Series A 15 (25%)
  • Series B 8 (13%)
  • Funding Round 6 (10%)
  • Seed 5 (8%)
  • Series C 5 (8%)
See all 10 stages →

Team

NameTitleInvestmentsLinksEmail
Bozhe Liu General Manager & Director
General Manager & Director Total investments: 0 Find email
Du Lin Partner
Partner Total investments: 3 Find email

Investments

CompanyDescriptionRoundLinks
Boden Intelligence Boden Intelligence
BodenAI focuses on providing customers with high-quality data services, mainly providing a full range of process services Series A / May 31, 2026
Robot Era Robot Era
Robot era is an emerging technology business creates embodied intelligence and generic humanoid robot technologies and products. Xingdong Era is committed to the development of universal humanoid robots that can adapt to a wide range of fields, multiple scenarios, and high intelligence, striving to realize the beautiful vision of intelligent robotsentering thousands of households and integrating into the lights of thousands of homes. $200M / Venture - Series Unknown / Apr 27, 2026
Oricell Therapeutics Oricell Therapeutics
OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices for tumor immunotherapy. $110M / Venture - Series Unknown / Apr 09, 2026
Wutong Sensing Control
Wutong Sensing Control is a leading company that specializes in the research, development, and innovation of cutting-edge robotic mechanics and tactile sensing technologies. With a strong focus on advancing automation systems, the company aims to enhance the precision, efficiency, and adaptability of robotic applications in various industries,including manufacturing, healthcare, and consumer electronics. Series A / Feb 28, 2026
Xinge Video Xinge Video
Xinge Video offers services connected to the smart view big data solution and specializes in the connection, management, calculation, and use of video resources for government and corporate customers. Series B / Feb 03, 2026
Juwei Technology Juwei Technology
Juwei Technology is one of the “Four Little Dogs of Hangzhou,” a nickname given to a group of fast-growing, innovative tech startups from Hangzhou that are seen as emerging leaders in China’s next generation of technology companies. $14.4M / Series A / Jan 23, 2026
Haier New Energy Haier New Energy
Haier New Energy expands green and low-carbon solutions under the background of the "dual carbon" goal. $143.6M / Series B / Jan 19, 2026
Tianqing Sky Tianqing Sky
Tianqing Sky is an unmanned aerial platform developer, primarily involved in the development, and mass manufacture of advanced unmanned aerial systems. $14M / Series A / Sep 28, 2025
Zhongke Jilian Optoelectronics Zhongke Jilian Optoelectronics
Zhongke Jilian Optoelectronics is an optoelectronic integrated device solutions company that provides the manufacturing of core optoelectronic chips and devices. Series B / Sep 01, 2025
Glycogene Glycogene
Glycogene specializing in directed evolution, and specialists in nucleic acid chemistry. $13.9M / Series B / Aug 14, 2025
See all 60 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Puerto Rico
Poland
Sudan
Guernsey
Cameroon
Andorra
Colombia
Armenia
China
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Qatar
Albania
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Spain
Mongolia
Angola
Europe
Cyprus
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Lucion invest in?

Lucion invests primarily in Biotechnology, Manufacturing and Medical startups, most often at Series A and Series B stage. Most of the 60 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Lucion's check size?

Lucion typically joins rounds of $1.4M–$539M at Series A and $2.8M–$144M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Lucion participates in.

How do I contact Lucion?

Public channels for Lucion include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Lucion?

The team at Lucion includes Bozhe Liu (General Manager & Director) and Du Lin (Partner). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Lucion Lucion Find emails